nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0385	0.0879	CbGbCtD
Fulvestrant—CYP3A4—Trimethadione—epilepsy syndrome	0.0358	0.0817	CbGbCtD
Fulvestrant—CYP3A4—Felbamate—epilepsy syndrome	0.0358	0.0817	CbGbCtD
Fulvestrant—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0336	0.0768	CbGbCtD
Fulvestrant—CYP3A4—Clonazepam—epilepsy syndrome	0.0304	0.0694	CbGbCtD
Fulvestrant—CYP3A4—Clobazam—epilepsy syndrome	0.0292	0.0666	CbGbCtD
Fulvestrant—CYP3A4—Rufinamide—epilepsy syndrome	0.0248	0.0566	CbGbCtD
Fulvestrant—CYP3A4—Carbamazepine—epilepsy syndrome	0.0242	0.0552	CbGbCtD
Fulvestrant—CYP3A4—Primidone—epilepsy syndrome	0.0226	0.0515	CbGbCtD
Fulvestrant—CYP3A4—Phenytoin—epilepsy syndrome	0.0217	0.0495	CbGbCtD
Fulvestrant—CYP3A4—Propofol—epilepsy syndrome	0.0202	0.0462	CbGbCtD
Fulvestrant—CYP3A4—Acetazolamide—epilepsy syndrome	0.0193	0.0441	CbGbCtD
Fulvestrant—CYP3A4—Phenobarbital—epilepsy syndrome	0.0193	0.0441	CbGbCtD
Fulvestrant—CYP3A4—Midazolam—epilepsy syndrome	0.0191	0.0435	CbGbCtD
Fulvestrant—NR1H4—skull—epilepsy syndrome	0.0186	0.31	CbGeAlD
Fulvestrant—CYP3A4—Diazepam—epilepsy syndrome	0.0183	0.0418	CbGbCtD
Fulvestrant—CYP3A4—Zonisamide—epilepsy syndrome	0.0179	0.0408	CbGbCtD
Fulvestrant—CYP3A4—Valproic Acid—epilepsy syndrome	0.0144	0.033	CbGbCtD
Fulvestrant—CYP3A4—Topiramate—epilepsy syndrome	0.013	0.0297	CbGbCtD
Fulvestrant—ESR2—hindbrain—epilepsy syndrome	0.00336	0.0563	CbGeAlD
Fulvestrant—ESR1—hindbrain—epilepsy syndrome	0.0023	0.0385	CbGeAlD
Fulvestrant—ESRRA—medulla oblongata—epilepsy syndrome	0.00224	0.0375	CbGeAlD
Fulvestrant—ESRRA—midbrain—epilepsy syndrome	0.00205	0.0342	CbGeAlD
Fulvestrant—ESRRA—spinal cord—epilepsy syndrome	0.002	0.0334	CbGeAlD
Fulvestrant—ESR2—brainstem—epilepsy syndrome	0.00193	0.0322	CbGeAlD
Fulvestrant—ESR2—forebrain—epilepsy syndrome	0.00186	0.0311	CbGeAlD
Fulvestrant—EPHX2—cerebellum—epilepsy syndrome	0.00181	0.0302	CbGeAlD
Fulvestrant—ESRRA—head—epilepsy syndrome	0.00178	0.0297	CbGeAlD
Fulvestrant—ESR2—telencephalon—epilepsy syndrome	0.00171	0.0286	CbGeAlD
Fulvestrant—ESRRA—nervous system—epilepsy syndrome	0.00168	0.0281	CbGeAlD
Fulvestrant—ESRRA—central nervous system—epilepsy syndrome	0.00162	0.0271	CbGeAlD
Fulvestrant—ESRRA—cerebellum—epilepsy syndrome	0.00158	0.0265	CbGeAlD
Fulvestrant—Estradiol—SLCO1A2—epilepsy syndrome	0.00158	0.473	CrCbGaD
Fulvestrant—EPHX2—brain—epilepsy syndrome	0.00147	0.0246	CbGeAlD
Fulvestrant—ESR1—brainstem—epilepsy syndrome	0.00132	0.0221	CbGeAlD
Fulvestrant—ESRRA—brain—epilepsy syndrome	0.00129	0.0215	CbGeAlD
Fulvestrant—ESR1—forebrain—epilepsy syndrome	0.00127	0.0213	CbGeAlD
Fulvestrant—ESR1—telencephalon—epilepsy syndrome	0.00117	0.0196	CbGeAlD
Fulvestrant—ESR2—head—epilepsy syndrome	0.00107	0.0178	CbGeAlD
Fulvestrant—ESR2—nervous system—epilepsy syndrome	0.00101	0.0169	CbGeAlD
Fulvestrant—ESR2—central nervous system—epilepsy syndrome	0.000973	0.0163	CbGeAlD
Fulvestrant—ESR2—cerebellum—epilepsy syndrome	0.000951	0.0159	CbGeAlD
Fulvestrant—ESR2—brain—epilepsy syndrome	0.000772	0.0129	CbGeAlD
Fulvestrant—ESR1—head—epilepsy syndrome	0.00073	0.0122	CbGeAlD
Fulvestrant—ESR1—nervous system—epilepsy syndrome	0.000692	0.0116	CbGeAlD
Fulvestrant—Estradiol—ABCG2—epilepsy syndrome	0.00067	0.2	CrCbGaD
Fulvestrant—ESR1—central nervous system—epilepsy syndrome	0.000666	0.0111	CbGeAlD
Fulvestrant—ESR1—cerebellum—epilepsy syndrome	0.000651	0.0109	CbGeAlD
Fulvestrant—ESR1—brain—epilepsy syndrome	0.000529	0.00884	CbGeAlD
Fulvestrant—Estradiol—CYP2C19—epilepsy syndrome	0.000526	0.157	CrCbGaD
Fulvestrant—CYP3A4—nervous system—epilepsy syndrome	0.000386	0.00646	CbGeAlD
Fulvestrant—CYP3A4—central nervous system—epilepsy syndrome	0.000372	0.00622	CbGeAlD
Fulvestrant—Estradiol—ALB—epilepsy syndrome	0.000292	0.0871	CrCbGaD
Fulvestrant—Estradiol—ABCB1—epilepsy syndrome	0.000279	0.0832	CrCbGaD
Fulvestrant—Diarrhoea—Diazepam—epilepsy syndrome	0.000176	0.000525	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000176	0.000525	CcSEcCtD
Fulvestrant—Rash—Levetiracetam—epilepsy syndrome	0.000175	0.000522	CcSEcCtD
Fulvestrant—Anaemia—Pregabalin—epilepsy syndrome	0.000175	0.000522	CcSEcCtD
Fulvestrant—Dermatitis—Levetiracetam—epilepsy syndrome	0.000175	0.000522	CcSEcCtD
Fulvestrant—Asthenia—Zonisamide—epilepsy syndrome	0.000175	0.000521	CcSEcCtD
Fulvestrant—Headache—Levetiracetam—epilepsy syndrome	0.000174	0.000519	CcSEcCtD
Fulvestrant—Malnutrition—Gabapentin—epilepsy syndrome	0.000174	0.000518	CcSEcCtD
Fulvestrant—Angioedema—Pregabalin—epilepsy syndrome	0.000173	0.000516	CcSEcCtD
Fulvestrant—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000173	0.000516	CcSEcCtD
Fulvestrant—Dizziness—Vigabatrin—epilepsy syndrome	0.000173	0.000515	CcSEcCtD
Fulvestrant—Pruritus—Zonisamide—epilepsy syndrome	0.000173	0.000514	CcSEcCtD
Fulvestrant—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000172	0.000513	CcSEcCtD
Fulvestrant—Urticaria—Lamotrigine—epilepsy syndrome	0.000171	0.00051	CcSEcCtD
Fulvestrant—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000171	0.00051	CcSEcCtD
Fulvestrant—Nausea—Propofol—epilepsy syndrome	0.000171	0.000509	CcSEcCtD
Fulvestrant—Vomiting—Fosphenytoin—epilepsy syndrome	0.000171	0.000508	CcSEcCtD
Fulvestrant—Diarrhoea—Felbamate—epilepsy syndrome	0.000171	0.000508	CcSEcCtD
Fulvestrant—Vertigo—Pregabalin—epilepsy syndrome	0.00017	0.000508	CcSEcCtD
Fulvestrant—Abdominal pain—Lamotrigine—epilepsy syndrome	0.00017	0.000507	CcSEcCtD
Fulvestrant—Body temperature increased—Lamotrigine—epilepsy syndrome	0.00017	0.000507	CcSEcCtD
Fulvestrant—Dizziness—Diazepam—epilepsy syndrome	0.00017	0.000507	CcSEcCtD
Fulvestrant—Infection—Valproic Acid—epilepsy syndrome	0.00017	0.000507	CcSEcCtD
Fulvestrant—Leukopenia—Pregabalin—epilepsy syndrome	0.00017	0.000506	CcSEcCtD
Fulvestrant—Rash—Fosphenytoin—epilepsy syndrome	0.000169	0.000504	CcSEcCtD
Fulvestrant—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000169	0.000504	CcSEcCtD
Fulvestrant—Haemoglobin—Topiramate—epilepsy syndrome	0.000169	0.000503	CcSEcCtD
Fulvestrant—Asthenia—Clonazepam—epilepsy syndrome	0.000169	0.000503	CcSEcCtD
Fulvestrant—Back pain—Gabapentin—epilepsy syndrome	0.000168	0.000501	CcSEcCtD
Fulvestrant—Headache—Fosphenytoin—epilepsy syndrome	0.000168	0.000501	CcSEcCtD
Fulvestrant—Haemorrhage—Topiramate—epilepsy syndrome	0.000168	0.000501	CcSEcCtD
Fulvestrant—Hepatitis—Topiramate—epilepsy syndrome	0.000168	0.000501	CcSEcCtD
Fulvestrant—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000168	0.0005	CcSEcCtD
Fulvestrant—Asthenia—Phenytoin—epilepsy syndrome	0.000168	0.000499	CcSEcCtD
Fulvestrant—Nausea—Midazolam—epilepsy syndrome	0.000167	0.000498	CcSEcCtD
Fulvestrant—Diarrhoea—Zonisamide—epilepsy syndrome	0.000167	0.000497	CcSEcCtD
Fulvestrant—Pharyngitis—Topiramate—epilepsy syndrome	0.000167	0.000497	CcSEcCtD
Fulvestrant—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000167	0.000497	CcSEcCtD
Fulvestrant—Pruritus—Clonazepam—epilepsy syndrome	0.000166	0.000496	CcSEcCtD
Fulvestrant—Vomiting—Vigabatrin—epilepsy syndrome	0.000166	0.000495	CcSEcCtD
Fulvestrant—Skin disorder—Valproic Acid—epilepsy syndrome	0.000166	0.000495	CcSEcCtD
Fulvestrant—Oedema peripheral—Topiramate—epilepsy syndrome	0.000166	0.000493	CcSEcCtD
Fulvestrant—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000166	0.000493	CcSEcCtD
Fulvestrant—Cough—Pregabalin—epilepsy syndrome	0.000166	0.000493	CcSEcCtD
Fulvestrant—Pruritus—Phenytoin—epilepsy syndrome	0.000165	0.000492	CcSEcCtD
Fulvestrant—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000165	0.000492	CcSEcCtD
Fulvestrant—Nausea—Levetiracetam—epilepsy syndrome	0.000165	0.000492	CcSEcCtD
Fulvestrant—Rash—Vigabatrin—epilepsy syndrome	0.000165	0.000491	CcSEcCtD
Fulvestrant—Dizziness—Felbamate—epilepsy syndrome	0.000165	0.000491	CcSEcCtD
Fulvestrant—Dermatitis—Vigabatrin—epilepsy syndrome	0.000165	0.000491	CcSEcCtD
Fulvestrant—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000164	0.00049	CcSEcCtD
Fulvestrant—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000164	0.000489	CcSEcCtD
Fulvestrant—Headache—Vigabatrin—epilepsy syndrome	0.000164	0.000488	CcSEcCtD
Fulvestrant—Vomiting—Diazepam—epilepsy syndrome	0.000164	0.000488	CcSEcCtD
Fulvestrant—Anorexia—Valproic Acid—epilepsy syndrome	0.000163	0.000486	CcSEcCtD
Fulvestrant—Rash—Diazepam—epilepsy syndrome	0.000162	0.000484	CcSEcCtD
Fulvestrant—Dermatitis—Diazepam—epilepsy syndrome	0.000162	0.000483	CcSEcCtD
Fulvestrant—Myalgia—Pregabalin—epilepsy syndrome	0.000161	0.000481	CcSEcCtD
Fulvestrant—Arthralgia—Pregabalin—epilepsy syndrome	0.000161	0.000481	CcSEcCtD
Fulvestrant—Chest pain—Pregabalin—epilepsy syndrome	0.000161	0.000481	CcSEcCtD
Fulvestrant—Dizziness—Zonisamide—epilepsy syndrome	0.000161	0.000481	CcSEcCtD
Fulvestrant—Headache—Diazepam—epilepsy syndrome	0.000161	0.000481	CcSEcCtD
Fulvestrant—Anxiety—Pregabalin—epilepsy syndrome	0.000161	0.000479	CcSEcCtD
Fulvestrant—Diarrhoea—Clonazepam—epilepsy syndrome	0.000161	0.000479	CcSEcCtD
Fulvestrant—Anaemia—Gabapentin—epilepsy syndrome	0.000161	0.000479	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.00016	0.000478	CcSEcCtD
Fulvestrant—Asthenia—Carbamazepine—epilepsy syndrome	0.00016	0.000476	CcSEcCtD
Fulvestrant—Diarrhoea—Phenytoin—epilepsy syndrome	0.00016	0.000476	CcSEcCtD
Fulvestrant—Nausea—Fosphenytoin—epilepsy syndrome	0.000159	0.000475	CcSEcCtD
Fulvestrant—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000159	0.000474	CcSEcCtD
Fulvestrant—Angioedema—Gabapentin—epilepsy syndrome	0.000159	0.000473	CcSEcCtD
Fulvestrant—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000159	0.000473	CcSEcCtD
Fulvestrant—Vomiting—Felbamate—epilepsy syndrome	0.000158	0.000472	CcSEcCtD
Fulvestrant—Pruritus—Carbamazepine—epilepsy syndrome	0.000158	0.00047	CcSEcCtD
Fulvestrant—Rash—Felbamate—epilepsy syndrome	0.000157	0.000468	CcSEcCtD
Fulvestrant—Dermatitis—Felbamate—epilepsy syndrome	0.000157	0.000468	CcSEcCtD
Fulvestrant—Vertigo—Gabapentin—epilepsy syndrome	0.000156	0.000465	CcSEcCtD
Fulvestrant—Headache—Felbamate—epilepsy syndrome	0.000156	0.000465	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000156	0.000465	CcSEcCtD
Fulvestrant—Leukopenia—Gabapentin—epilepsy syndrome	0.000156	0.000464	CcSEcCtD
Fulvestrant—Dizziness—Clonazepam—epilepsy syndrome	0.000156	0.000463	CcSEcCtD
Fulvestrant—Nausea—Vigabatrin—epilepsy syndrome	0.000155	0.000463	CcSEcCtD
Fulvestrant—Vomiting—Zonisamide—epilepsy syndrome	0.000155	0.000462	CcSEcCtD
Fulvestrant—Insomnia—Valproic Acid—epilepsy syndrome	0.000155	0.000461	CcSEcCtD
Fulvestrant—Asthenia—Lamotrigine—epilepsy syndrome	0.000155	0.000461	CcSEcCtD
Fulvestrant—Dizziness—Phenytoin—epilepsy syndrome	0.000154	0.00046	CcSEcCtD
Fulvestrant—Rash—Zonisamide—epilepsy syndrome	0.000154	0.000458	CcSEcCtD
Fulvestrant—Infection—Pregabalin—epilepsy syndrome	0.000154	0.000458	CcSEcCtD
Fulvestrant—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000154	0.000458	CcSEcCtD
Fulvestrant—Dermatitis—Zonisamide—epilepsy syndrome	0.000154	0.000458	CcSEcCtD
Fulvestrant—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000154	0.000458	CcSEcCtD
Fulvestrant—Nausea—Diazepam—epilepsy syndrome	0.000153	0.000456	CcSEcCtD
Fulvestrant—Headache—Zonisamide—epilepsy syndrome	0.000153	0.000455	CcSEcCtD
Fulvestrant—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000153	0.000455	CcSEcCtD
Fulvestrant—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000153	0.000454	CcSEcCtD
Fulvestrant—Angiopathy—Topiramate—epilepsy syndrome	0.000153	0.000454	CcSEcCtD
Fulvestrant—Pruritus—Lamotrigine—epilepsy syndrome	0.000152	0.000454	CcSEcCtD
Fulvestrant—Immune system disorder—Topiramate—epilepsy syndrome	0.000152	0.000452	CcSEcCtD
Fulvestrant—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000152	0.000452	CcSEcCtD
Fulvestrant—Cough—Gabapentin—epilepsy syndrome	0.000152	0.000452	CcSEcCtD
Fulvestrant—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000151	0.000449	CcSEcCtD
Fulvestrant—Skin disorder—Pregabalin—epilepsy syndrome	0.00015	0.000448	CcSEcCtD
Fulvestrant—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.00015	0.000446	CcSEcCtD
Fulvestrant—Vomiting—Clonazepam—epilepsy syndrome	0.00015	0.000445	CcSEcCtD
Fulvestrant—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000149	0.000443	CcSEcCtD
Fulvestrant—Vomiting—Phenytoin—epilepsy syndrome	0.000149	0.000442	CcSEcCtD
Fulvestrant—Rash—Clonazepam—epilepsy syndrome	0.000148	0.000442	CcSEcCtD
Fulvestrant—Dermatitis—Clonazepam—epilepsy syndrome	0.000148	0.000441	CcSEcCtD
Fulvestrant—Myalgia—Gabapentin—epilepsy syndrome	0.000148	0.000441	CcSEcCtD
Fulvestrant—Chest pain—Gabapentin—epilepsy syndrome	0.000148	0.000441	CcSEcCtD
Fulvestrant—Arthralgia—Gabapentin—epilepsy syndrome	0.000148	0.000441	CcSEcCtD
Fulvestrant—Nausea—Felbamate—epilepsy syndrome	0.000148	0.000441	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000148	0.00044	CcSEcCtD
Fulvestrant—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000148	0.00044	CcSEcCtD
Fulvestrant—Fatigue—Valproic Acid—epilepsy syndrome	0.000148	0.00044	CcSEcCtD
Fulvestrant—Anxiety—Gabapentin—epilepsy syndrome	0.000148	0.00044	CcSEcCtD
Fulvestrant—Anorexia—Pregabalin—epilepsy syndrome	0.000148	0.00044	CcSEcCtD
Fulvestrant—Dizziness—Carbamazepine—epilepsy syndrome	0.000147	0.000439	CcSEcCtD
Fulvestrant—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000147	0.000439	CcSEcCtD
Fulvestrant—Headache—Clonazepam—epilepsy syndrome	0.000147	0.000439	CcSEcCtD
Fulvestrant—Rash—Phenytoin—epilepsy syndrome	0.000147	0.000439	CcSEcCtD
Fulvestrant—Dermatitis—Phenytoin—epilepsy syndrome	0.000147	0.000438	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000147	0.000438	CcSEcCtD
Fulvestrant—Rash—Oxcarbazepine—epilepsy syndrome	0.000146	0.000436	CcSEcCtD
Fulvestrant—Constipation—Valproic Acid—epilepsy syndrome	0.000146	0.000436	CcSEcCtD
Fulvestrant—Pain—Valproic Acid—epilepsy syndrome	0.000146	0.000436	CcSEcCtD
Fulvestrant—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000146	0.000436	CcSEcCtD
Fulvestrant—Headache—Phenytoin—epilepsy syndrome	0.000146	0.000436	CcSEcCtD
Fulvestrant—Malnutrition—Topiramate—epilepsy syndrome	0.000146	0.000436	CcSEcCtD
Fulvestrant—Headache—Oxcarbazepine—epilepsy syndrome	0.000146	0.000434	CcSEcCtD
Fulvestrant—Nausea—Zonisamide—epilepsy syndrome	0.000145	0.000432	CcSEcCtD
Fulvestrant—Dizziness—Lamotrigine—epilepsy syndrome	0.000142	0.000424	CcSEcCtD
Fulvestrant—Vomiting—Carbamazepine—epilepsy syndrome	0.000142	0.000422	CcSEcCtD
Fulvestrant—Back pain—Topiramate—epilepsy syndrome	0.000142	0.000422	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000141	0.00042	CcSEcCtD
Fulvestrant—Infection—Gabapentin—epilepsy syndrome	0.000141	0.00042	CcSEcCtD
Fulvestrant—Rash—Carbamazepine—epilepsy syndrome	0.000141	0.000419	CcSEcCtD
Fulvestrant—Dermatitis—Carbamazepine—epilepsy syndrome	0.00014	0.000418	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.00014	0.000417	CcSEcCtD
Fulvestrant—Insomnia—Pregabalin—epilepsy syndrome	0.00014	0.000417	CcSEcCtD
Fulvestrant—Nausea—Clonazepam—epilepsy syndrome	0.00014	0.000416	CcSEcCtD
Fulvestrant—Headache—Carbamazepine—epilepsy syndrome	0.00014	0.000416	CcSEcCtD
Fulvestrant—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000139	0.000415	CcSEcCtD
Fulvestrant—Paraesthesia—Pregabalin—epilepsy syndrome	0.000139	0.000414	CcSEcCtD
Fulvestrant—Nausea—Phenytoin—epilepsy syndrome	0.000139	0.000413	CcSEcCtD
Fulvestrant—Dyspnoea—Pregabalin—epilepsy syndrome	0.000138	0.000411	CcSEcCtD
Fulvestrant—Nausea—Oxcarbazepine—epilepsy syndrome	0.000138	0.000411	CcSEcCtD
Fulvestrant—Skin disorder—Gabapentin—epilepsy syndrome	0.000138	0.000411	CcSEcCtD
Fulvestrant—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000137	0.000409	CcSEcCtD
Fulvestrant—Vomiting—Lamotrigine—epilepsy syndrome	0.000137	0.000408	CcSEcCtD
Fulvestrant—Urticaria—Valproic Acid—epilepsy syndrome	0.000136	0.000405	CcSEcCtD
Fulvestrant—Rash—Lamotrigine—epilepsy syndrome	0.000136	0.000405	CcSEcCtD
Fulvestrant—Dermatitis—Lamotrigine—epilepsy syndrome	0.000136	0.000404	CcSEcCtD
Fulvestrant—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000135	0.000403	CcSEcCtD
Fulvestrant—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000135	0.000403	CcSEcCtD
Fulvestrant—Anorexia—Gabapentin—epilepsy syndrome	0.000135	0.000403	CcSEcCtD
Fulvestrant—Anaemia—Topiramate—epilepsy syndrome	0.000135	0.000403	CcSEcCtD
Fulvestrant—Headache—Lamotrigine—epilepsy syndrome	0.000135	0.000402	CcSEcCtD
Fulvestrant—Decreased appetite—Pregabalin—epilepsy syndrome	0.000135	0.000401	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000134	0.000398	CcSEcCtD
Fulvestrant—Fatigue—Pregabalin—epilepsy syndrome	0.000133	0.000398	CcSEcCtD
Fulvestrant—Nausea—Carbamazepine—epilepsy syndrome	0.000132	0.000394	CcSEcCtD
Fulvestrant—Pain—Pregabalin—epilepsy syndrome	0.000132	0.000394	CcSEcCtD
Fulvestrant—Constipation—Pregabalin—epilepsy syndrome	0.000132	0.000394	CcSEcCtD
Fulvestrant—Vertigo—Topiramate—epilepsy syndrome	0.000131	0.000392	CcSEcCtD
Fulvestrant—Leukopenia—Topiramate—epilepsy syndrome	0.000131	0.00039	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000129	0.000385	CcSEcCtD
Fulvestrant—Insomnia—Gabapentin—epilepsy syndrome	0.000128	0.000382	CcSEcCtD
Fulvestrant—Nausea—Lamotrigine—epilepsy syndrome	0.000128	0.000381	CcSEcCtD
Fulvestrant—Cough—Topiramate—epilepsy syndrome	0.000128	0.00038	CcSEcCtD
Fulvestrant—Paraesthesia—Gabapentin—epilepsy syndrome	0.000127	0.00038	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000127	0.000377	CcSEcCtD
Fulvestrant—Dyspnoea—Gabapentin—epilepsy syndrome	0.000127	0.000377	CcSEcCtD
Fulvestrant—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000126	0.000376	CcSEcCtD
Fulvestrant—Dyspepsia—Gabapentin—epilepsy syndrome	0.000125	0.000372	CcSEcCtD
Fulvestrant—Arthralgia—Topiramate—epilepsy syndrome	0.000125	0.000371	CcSEcCtD
Fulvestrant—Chest pain—Topiramate—epilepsy syndrome	0.000125	0.000371	CcSEcCtD
Fulvestrant—Myalgia—Topiramate—epilepsy syndrome	0.000125	0.000371	CcSEcCtD
Fulvestrant—Anxiety—Topiramate—epilepsy syndrome	0.000124	0.00037	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000124	0.000369	CcSEcCtD
Fulvestrant—Decreased appetite—Gabapentin—epilepsy syndrome	0.000123	0.000368	CcSEcCtD
Fulvestrant—Urticaria—Pregabalin—epilepsy syndrome	0.000123	0.000366	CcSEcCtD
Fulvestrant—Asthenia—Valproic Acid—epilepsy syndrome	0.000123	0.000366	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000123	0.000365	CcSEcCtD
Fulvestrant—Fatigue—Gabapentin—epilepsy syndrome	0.000122	0.000365	CcSEcCtD
Fulvestrant—Body temperature increased—Pregabalin—epilepsy syndrome	0.000122	0.000365	CcSEcCtD
Fulvestrant—Abdominal pain—Pregabalin—epilepsy syndrome	0.000122	0.000365	CcSEcCtD
Fulvestrant—Pain—Gabapentin—epilepsy syndrome	0.000121	0.000362	CcSEcCtD
Fulvestrant—Constipation—Gabapentin—epilepsy syndrome	0.000121	0.000362	CcSEcCtD
Fulvestrant—Pruritus—Valproic Acid—epilepsy syndrome	0.000121	0.000361	CcSEcCtD
Fulvestrant—Infection—Topiramate—epilepsy syndrome	0.000119	0.000353	CcSEcCtD
Fulvestrant—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000117	0.000349	CcSEcCtD
Fulvestrant—Nervous system disorder—Topiramate—epilepsy syndrome	0.000117	0.000349	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000116	0.000346	CcSEcCtD
Fulvestrant—Skin disorder—Topiramate—epilepsy syndrome	0.000116	0.000346	CcSEcCtD
Fulvestrant—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000115	0.000344	CcSEcCtD
Fulvestrant—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000114	0.00034	CcSEcCtD
Fulvestrant—Anorexia—Topiramate—epilepsy syndrome	0.000114	0.000339	CcSEcCtD
Fulvestrant—Dizziness—Valproic Acid—epilepsy syndrome	0.000113	0.000337	CcSEcCtD
Fulvestrant—Urticaria—Gabapentin—epilepsy syndrome	0.000113	0.000336	CcSEcCtD
Fulvestrant—Abdominal pain—Gabapentin—epilepsy syndrome	0.000112	0.000334	CcSEcCtD
Fulvestrant—Body temperature increased—Gabapentin—epilepsy syndrome	0.000112	0.000334	CcSEcCtD
Fulvestrant—Asthenia—Pregabalin—epilepsy syndrome	0.000111	0.000331	CcSEcCtD
Fulvestrant—Pruritus—Pregabalin—epilepsy syndrome	0.00011	0.000326	CcSEcCtD
Fulvestrant—Vomiting—Valproic Acid—epilepsy syndrome	0.000109	0.000324	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000109	0.000324	CcSEcCtD
Fulvestrant—Insomnia—Topiramate—epilepsy syndrome	0.000108	0.000322	CcSEcCtD
Fulvestrant—Rash—Valproic Acid—epilepsy syndrome	0.000108	0.000322	CcSEcCtD
Fulvestrant—Dermatitis—Valproic Acid—epilepsy syndrome	0.000108	0.000321	CcSEcCtD
Fulvestrant—Headache—Valproic Acid—epilepsy syndrome	0.000107	0.00032	CcSEcCtD
Fulvestrant—Paraesthesia—Topiramate—epilepsy syndrome	0.000107	0.000319	CcSEcCtD
Fulvestrant—Dyspnoea—Topiramate—epilepsy syndrome	0.000106	0.000317	CcSEcCtD
Fulvestrant—Diarrhoea—Pregabalin—epilepsy syndrome	0.000106	0.000315	CcSEcCtD
Fulvestrant—Dyspepsia—Topiramate—epilepsy syndrome	0.000105	0.000313	CcSEcCtD
Fulvestrant—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000105	0.000312	CcSEcCtD
Fulvestrant—Decreased appetite—Topiramate—epilepsy syndrome	0.000104	0.000309	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000103	0.000307	CcSEcCtD
Fulvestrant—Fatigue—Topiramate—epilepsy syndrome	0.000103	0.000307	CcSEcCtD
Fulvestrant—Dizziness—Pregabalin—epilepsy syndrome	0.000102	0.000305	CcSEcCtD
Fulvestrant—Pain—Topiramate—epilepsy syndrome	0.000102	0.000304	CcSEcCtD
Fulvestrant—Constipation—Topiramate—epilepsy syndrome	0.000102	0.000304	CcSEcCtD
Fulvestrant—Asthenia—Gabapentin—epilepsy syndrome	0.000102	0.000303	CcSEcCtD
Fulvestrant—Nausea—Valproic Acid—epilepsy syndrome	0.000102	0.000303	CcSEcCtD
Fulvestrant—Pruritus—Gabapentin—epilepsy syndrome	0.0001	0.000299	CcSEcCtD
Fulvestrant—Vomiting—Pregabalin—epilepsy syndrome	9.84e-05	0.000293	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Topiramate—epilepsy syndrome	9.77e-05	0.000291	CcSEcCtD
Fulvestrant—Rash—Pregabalin—epilepsy syndrome	9.76e-05	0.000291	CcSEcCtD
Fulvestrant—Dermatitis—Pregabalin—epilepsy syndrome	9.75e-05	0.00029	CcSEcCtD
Fulvestrant—Diarrhoea—Gabapentin—epilepsy syndrome	9.71e-05	0.000289	CcSEcCtD
Fulvestrant—Headache—Pregabalin—epilepsy syndrome	9.7e-05	0.000289	CcSEcCtD
Fulvestrant—Urticaria—Topiramate—epilepsy syndrome	9.49e-05	0.000283	CcSEcCtD
Fulvestrant—Abdominal pain—Topiramate—epilepsy syndrome	9.44e-05	0.000281	CcSEcCtD
Fulvestrant—Body temperature increased—Topiramate—epilepsy syndrome	9.44e-05	0.000281	CcSEcCtD
Fulvestrant—Dizziness—Gabapentin—epilepsy syndrome	9.39e-05	0.00028	CcSEcCtD
Fulvestrant—Nausea—Pregabalin—epilepsy syndrome	9.19e-05	0.000274	CcSEcCtD
Fulvestrant—Vomiting—Gabapentin—epilepsy syndrome	9.03e-05	0.000269	CcSEcCtD
Fulvestrant—Rash—Gabapentin—epilepsy syndrome	8.95e-05	0.000267	CcSEcCtD
Fulvestrant—Dermatitis—Gabapentin—epilepsy syndrome	8.94e-05	0.000266	CcSEcCtD
Fulvestrant—Headache—Gabapentin—epilepsy syndrome	8.89e-05	0.000265	CcSEcCtD
Fulvestrant—Hypersensitivity—Topiramate—epilepsy syndrome	8.8e-05	0.000262	CcSEcCtD
Fulvestrant—Asthenia—Topiramate—epilepsy syndrome	8.57e-05	0.000255	CcSEcCtD
Fulvestrant—Pruritus—Topiramate—epilepsy syndrome	8.45e-05	0.000252	CcSEcCtD
Fulvestrant—Nausea—Gabapentin—epilepsy syndrome	8.43e-05	0.000251	CcSEcCtD
Fulvestrant—Diarrhoea—Topiramate—epilepsy syndrome	8.17e-05	0.000243	CcSEcCtD
Fulvestrant—Dizziness—Topiramate—epilepsy syndrome	7.9e-05	0.000235	CcSEcCtD
Fulvestrant—Vomiting—Topiramate—epilepsy syndrome	7.59e-05	0.000226	CcSEcCtD
Fulvestrant—Rash—Topiramate—epilepsy syndrome	7.53e-05	0.000224	CcSEcCtD
Fulvestrant—Dermatitis—Topiramate—epilepsy syndrome	7.52e-05	0.000224	CcSEcCtD
Fulvestrant—Headache—Topiramate—epilepsy syndrome	7.48e-05	0.000223	CcSEcCtD
Fulvestrant—Nausea—Topiramate—epilepsy syndrome	7.09e-05	0.000211	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—YWHAZ—epilepsy syndrome	5.04e-05	0.00031	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ABCG2—epilepsy syndrome	5.03e-05	0.000309	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GPX1—epilepsy syndrome	5e-05	0.000307	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRDM4—epilepsy syndrome	4.99e-05	0.000306	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRICKLE1—epilepsy syndrome	4.99e-05	0.000306	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	4.98e-05	0.000305	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NR3C1—epilepsy syndrome	4.96e-05	0.000305	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	4.94e-05	0.000303	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—MTOR—epilepsy syndrome	4.92e-05	0.000302	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP2C19—epilepsy syndrome	4.9e-05	0.000301	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP11A1—epilepsy syndrome	4.87e-05	0.000299	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.84e-05	0.000297	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—AKT1—epilepsy syndrome	4.66e-05	0.000286	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—JUNB—epilepsy syndrome	4.63e-05	0.000284	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—TFAM—epilepsy syndrome	4.6e-05	0.000282	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	4.55e-05	0.000279	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	4.5e-05	0.000276	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—HMOX1—epilepsy syndrome	4.48e-05	0.000275	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—JUNB—epilepsy syndrome	4.42e-05	0.000271	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CAT—epilepsy syndrome	4.42e-05	0.000271	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	4.42e-05	0.000271	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.41e-05	0.000271	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP2D6—epilepsy syndrome	4.4e-05	0.00027	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AGT—epilepsy syndrome	4.38e-05	0.000269	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ACKR4—epilepsy syndrome	4.36e-05	0.000268	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—AKT1—epilepsy syndrome	4.31e-05	0.000264	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ABCB1—epilepsy syndrome	4.3e-05	0.000264	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—APOE—epilepsy syndrome	4.29e-05	0.000263	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	4.27e-05	0.000262	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.19e-05	0.000257	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.19e-05	0.000257	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ADRA2A—epilepsy syndrome	4.19e-05	0.000257	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—BCHE—epilepsy syndrome	4.17e-05	0.000256	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	4.1e-05	0.000252	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SIRT1—epilepsy syndrome	4.09e-05	0.000251	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	4.08e-05	0.00025	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	4.06e-05	0.000249	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	4.05e-05	0.000249	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.05e-05	0.000248	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.05e-05	0.000248	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—VDR—epilepsy syndrome	4.03e-05	0.000247	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.02e-05	0.000247	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GPX1—epilepsy syndrome	4e-05	0.000245	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SLC2A1—epilepsy syndrome	3.98e-05	0.000244	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SNRPE—epilepsy syndrome	3.97e-05	0.000244	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SSTR5—epilepsy syndrome	3.95e-05	0.000242	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SSTR4—epilepsy syndrome	3.95e-05	0.000242	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PLCB1—epilepsy syndrome	3.93e-05	0.000241	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—TH—epilepsy syndrome	3.92e-05	0.000241	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.86e-05	0.000237	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	3.86e-05	0.000237	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—H2AFX—epilepsy syndrome	3.82e-05	0.000234	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR10—epilepsy syndrome	3.78e-05	0.000232	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	3.77e-05	0.000231	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—POMC—epilepsy syndrome	3.69e-05	0.000226	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—YWHAZ—epilepsy syndrome	3.69e-05	0.000226	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	3.68e-05	0.000226	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—VDR—epilepsy syndrome	3.68e-05	0.000226	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	3.66e-05	0.000225	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.63e-05	0.000223	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NR3C1—epilepsy syndrome	3.63e-05	0.000223	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SIRT1—epilepsy syndrome	3.56e-05	0.000219	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—VDR—epilepsy syndrome	3.51e-05	0.000215	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AGT—epilepsy syndrome	3.5e-05	0.000215	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APOE—epilepsy syndrome	3.43e-05	0.000211	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.4e-05	0.000208	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ALB—epilepsy syndrome	3.36e-05	0.000206	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—H2AFX—epilepsy syndrome	3.33e-05	0.000204	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NR3C1—epilepsy syndrome	3.31e-05	0.000203	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRM2—epilepsy syndrome	3.31e-05	0.000203	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	3.28e-05	0.000201	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HMOX1—epilepsy syndrome	3.27e-05	0.000201	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CAT—epilepsy syndrome	3.23e-05	0.000198	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—YWHAZ—epilepsy syndrome	3.21e-05	0.000197	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	3.2e-05	0.000196	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NR3C1—epilepsy syndrome	3.16e-05	0.000194	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ABCB1—epilepsy syndrome	3.14e-05	0.000193	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SSTR3—epilepsy syndrome	2.99e-05	0.000184	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—POMC—epilepsy syndrome	2.95e-05	0.000181	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—epilepsy syndrome	2.94e-05	0.000181	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	2.93e-05	0.00018	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GPX1—epilepsy syndrome	2.92e-05	0.000179	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR8—epilepsy syndrome	2.87e-05	0.000176	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	2.87e-05	0.000176	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NPY2R—epilepsy syndrome	2.87e-05	0.000176	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SSTR1—epilepsy syndrome	2.87e-05	0.000176	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR9—epilepsy syndrome	2.87e-05	0.000176	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRM4—epilepsy syndrome	2.81e-05	0.000173	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRM3—epilepsy syndrome	2.81e-05	0.000173	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.81e-05	0.000172	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—EIF2S1—epilepsy syndrome	2.77e-05	0.00017	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SSTR2—epilepsy syndrome	2.76e-05	0.000169	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DUSP4—epilepsy syndrome	2.76e-05	0.000169	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.74e-05	0.000168	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ALB—epilepsy syndrome	2.69e-05	0.000165	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPB1—epilepsy syndrome	2.67e-05	0.000164	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRM8—epilepsy syndrome	2.67e-05	0.000164	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PGF—epilepsy syndrome	2.67e-05	0.000164	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AGT—epilepsy syndrome	2.56e-05	0.000157	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—OPRD1—epilepsy syndrome	2.54e-05	0.000156	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GNAO1—epilepsy syndrome	2.54e-05	0.000156	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOE—epilepsy syndrome	2.51e-05	0.000154	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	2.46e-05	0.000151	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—AKT1—epilepsy syndrome	2.45e-05	0.00015	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR7—epilepsy syndrome	2.44e-05	0.00015	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CHRM1—epilepsy syndrome	2.44e-05	0.00015	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRM1—epilepsy syndrome	2.44e-05	0.00015	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDYN—epilepsy syndrome	2.44e-05	0.00015	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—epilepsy syndrome	2.35e-05	0.000144	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GAL—epilepsy syndrome	2.29e-05	0.000141	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GFAP—epilepsy syndrome	2.29e-05	0.000141	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CHRM3—epilepsy syndrome	2.27e-05	0.000139	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASP2—epilepsy syndrome	2.27e-05	0.000139	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRM5—epilepsy syndrome	2.27e-05	0.000139	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—JUNB—epilepsy syndrome	2.23e-05	0.000137	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.17e-05	0.000133	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—POMC—epilepsy syndrome	2.15e-05	0.000132	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CHRM2—epilepsy syndrome	2.13e-05	0.000131	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.13e-05	0.000131	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.13e-05	0.000131	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.13e-05	0.000131	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.13e-05	0.000131	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.13e-05	0.000131	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.13e-05	0.000131	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.13e-05	0.000131	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.13e-05	0.000131	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GABBR1—epilepsy syndrome	2.07e-05	0.000127	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.04e-05	0.000125	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HRH3—epilepsy syndrome	1.99e-05	0.000122	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—epilepsy syndrome	1.96e-05	0.000121	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—OPRM1—epilepsy syndrome	1.96e-05	0.00012	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.95e-05	0.000119	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.95e-05	0.000119	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.95e-05	0.000119	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.95e-05	0.000119	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR3—epilepsy syndrome	1.85e-05	0.000113	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.81e-05	0.000111	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.81e-05	0.000111	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.8e-05	0.000111	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NPY—epilepsy syndrome	1.8e-05	0.00011	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.8e-05	0.00011	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SIRT1—epilepsy syndrome	1.8e-05	0.00011	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—VDR—epilepsy syndrome	1.77e-05	0.000109	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—OXT—epilepsy syndrome	1.74e-05	0.000107	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HSPB1—epilepsy syndrome	1.74e-05	0.000107	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL2—epilepsy syndrome	1.74e-05	0.000107	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL3—epilepsy syndrome	1.74e-05	0.000107	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CRH—epilepsy syndrome	1.74e-05	0.000107	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—epilepsy syndrome	1.72e-05	0.000105	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.7e-05	0.000104	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—H2AFX—epilepsy syndrome	1.68e-05	0.000103	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—YWHAZ—epilepsy syndrome	1.62e-05	9.93e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TSC1—epilepsy syndrome	1.62e-05	9.91e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTK2B—epilepsy syndrome	1.62e-05	9.91e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.61e-05	9.9e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.61e-05	9.9e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.61e-05	9.9e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.61e-05	9.9e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.61e-05	9.9e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NR3C1—epilepsy syndrome	1.59e-05	9.78e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR2—epilepsy syndrome	1.57e-05	9.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NTRK2—epilepsy syndrome	1.57e-05	9.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SST—epilepsy syndrome	1.57e-05	9.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DUSP6—epilepsy syndrome	1.56e-05	9.56e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.54e-05	9.43e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLAT—epilepsy syndrome	1.53e-05	9.39e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—AKT1—epilepsy syndrome	1.52e-05	9.33e-05	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AKT1—epilepsy syndrome	1.48e-05	9.07e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.48e-05	9.06e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL12—epilepsy syndrome	1.48e-05	9.06e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.48e-05	9.05e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.48e-05	9.05e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.48e-05	9.05e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CNR1—epilepsy syndrome	1.45e-05	8.9e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JUNB—epilepsy syndrome	1.45e-05	8.9e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLCB1—epilepsy syndrome	1.44e-05	8.86e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.42e-05	8.71e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR7—epilepsy syndrome	1.41e-05	8.68e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HBEGF—epilepsy syndrome	1.37e-05	8.43e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.37e-05	8.41e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.37e-05	8.41e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT3—epilepsy syndrome	1.35e-05	8.27e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADAM10—epilepsy syndrome	1.32e-05	8.08e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.29e-05	7.91e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.25e-05	7.7e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—S100B—epilepsy syndrome	1.25e-05	7.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SOCS3—epilepsy syndrome	1.23e-05	7.56e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDC42—epilepsy syndrome	1.23e-05	7.55e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.22e-05	7.5e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.22e-05	7.5e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AVP—epilepsy syndrome	1.19e-05	7.31e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKT1—epilepsy syndrome	1.18e-05	7.25e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.17e-05	7.15e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.17e-05	7.15e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.14e-05	7e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HES1—epilepsy syndrome	1.13e-05	6.91e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.12e-05	6.86e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—AKT1—epilepsy syndrome	1.11e-05	6.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.1e-05	6.73e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FYN—epilepsy syndrome	1.09e-05	6.72e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—H2AFX—epilepsy syndrome	1.09e-05	6.69e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MEF2C—epilepsy syndrome	1.09e-05	6.68e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.08e-05	6.6e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.05e-05	6.46e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NGF—epilepsy syndrome	1.04e-05	6.39e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR5—epilepsy syndrome	1.01e-05	6.21e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.01e-05	6.18e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR2A—epilepsy syndrome	9.91e-06	6.08e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AQP1—epilepsy syndrome	9.77e-06	6e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—AKT1—epilepsy syndrome	9.68e-06	5.94e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TSC2—epilepsy syndrome	9.41e-06	5.78e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGT—epilepsy syndrome	9.4e-06	5.77e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOE—epilepsy syndrome	9.21e-06	5.65e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KDR—epilepsy syndrome	9.02e-06	5.54e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	8.84e-06	5.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	8.84e-06	5.42e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKCB—epilepsy syndrome	8.69e-06	5.33e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6ST—epilepsy syndrome	8.65e-06	5.31e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKT1—epilepsy syndrome	8.64e-06	5.3e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—POMC—epilepsy syndrome	7.91e-06	4.86e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL2—epilepsy syndrome	7.74e-06	4.75e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.2e-06	4.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.02e-06	4.31e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGF2—epilepsy syndrome	7e-06	4.29e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.98e-06	4.28e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RELA—epilepsy syndrome	6.5e-06	3.99e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MTOR—epilepsy syndrome	6.37e-06	3.91e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.3e-06	3.86e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.99e-06	3.68e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.97e-06	3.66e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASP3—epilepsy syndrome	5.86e-06	3.59e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.69e-06	3.49e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JUN—epilepsy syndrome	5.69e-06	3.49e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.63e-06	3.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TH—epilepsy syndrome	5.61e-06	3.44e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—epilepsy syndrome	5.54e-06	3.4e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SRC—epilepsy syndrome	5.1e-06	3.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—epilepsy syndrome	4.97e-06	3.05e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AKT1—epilepsy syndrome	4.88e-06	2.99e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.68e-06	2.87e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.62e-06	2.84e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.5e-06	2.76e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.18e-06	2.56e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.66e-06	2.25e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.59e-06	2.2e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT1—epilepsy syndrome	3.17e-06	1.95e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.08e-06	1.89e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.81e-06	1.73e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.46e-06	1.51e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.24e-06	7.59e-06	CbGpPWpGaD
